Overview
Medical office building owner's Q4 same-store cash NOI grew 5.5%
Company completed $682 mln asset sales, refining core portfolio
Company repurchased 2.9 mln shares at $17.27 each, totaling $50 mln
Outlook
Healthcare Realty Trust expects 2026 EPS between $(0.05) and $0.05
Company forecasts 2026 NAREIT FFO per share of $1.44 to $1.50
Healthcare Realty Trust projects 2026 Same Store Cash NOI growth of 3.5% to 4.5%
Result Drivers
LEASING ACTIVITY - Strong leasing activity with 1.5 mln sq ft executed, including renewals and new leases, contributing to same-store cash NOI growth
ASSET SALES - Completed $682 mln in asset sales to refine core portfolio, including strategic market exits
REDEVELOPMENT PROJECTS - Sequential lease-up of over 500 bps in redevelopment projects versus prior quarter
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Adjusted FFO
$142.15 mln
Q4 FFO
$126.98 mln
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy."
Wall Street's median 12-month price target for Healthcare Realty Trust Inc is $19.00, about 9.3% above its February 11 closing price of $17.39
Press Release: ID:nGNX4Zr53v
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)